Latest News and Press Releases
Want to stay updated on the latest news?
-
DISCO Pharmaceuticals Enters License Agreement to Advance Novel Cancer Surfaceome Targeted Therapies
DISCO signs exclusive deal with Amgen to develop cancer therapies from its surfaceome platform; deal worth up to $618M plus royalties.